Navigation Links
MannKind to Present at the Wachovia 2008 Healthcare Conference
Date:1/25/2008

VALENCIA, Calif., Jan. 25 /PRNewswire-FirstCall/ -- MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Wachovia Healthcare Conference on January 30, 2008 at 2:00 PM ET at the Langham Hotel in Boston, MA.

Interested parties can access a link to the live web cast of the presentation in the Investor Relations section of the Company's website at http://www.mannkindcorp.com. A replay of the presentation will be available for 14 days.

About MannKind Corporation

MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. Its lead product, the Technosphere(R) Insulin System, is currently in phase 3 clinical trials in the United States, Europe and Latin America to study its safety and efficacy in the treatment of diabetes. For more information on MannKind Corporation and its technology, visit http://www.mannkindcorp.com.


'/>"/>
SOURCE MannKind Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. MannKind to Present at the UBS Global Life Sciences Conference
2. MannKind Corporation Raises $250 Million in Self Managed Registered Direct Offerings of Common Stock
3. MannKind Announces Positive Results from a Phase 1a Study of a GLP-1 Formulation
4. MannKind to Present at the Piper Jaffray Healthcare Conference
5. Imagenetix Inc. to Present at Noble Small Cap Financial Conference on August 21, 2007
6. Avicena Group to Present at Noble Financial Conference
7. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
8. Strategic Diagnostics to Present at Two Upcoming Investor Conferences
9. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
10. CEL-SCI to Present at the Noble Financial Conference
11. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...ANMATEO,Calif.,Nov.24/PRNewswire-FirstCall/--Neuro...focusedondevelopingandcommercializingnovelpainmana...residentandChiefExecutiveOfficer,isscheduledtopres...,tobeheldDecember1-2,2009atTheNewYorkPalaceHotelin...ri,ChiefFinancialOfficer,willbeavailabletorespondt...
(Date:11/24/2009)...rimaryefficacyendpointhasbeenmetforpatientswithadv...UEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZent...balbiopharmaceuticalcompanyfocusedonendocrinethera...omaPhase2studywithitstargetedcytotoxicpeptideconju...edorrecurrentendometrialcancer.Inapersonalizedheal...
(Date:11/24/2009)..., REDWOOD CITY, Calif., Nov. 24 /PRNewswire-Fir...oday announced that Randy Scott, Genomic Health,s ...l Piper Jaffray Health Care Conference in New York...T. ,, To access the live and subsequently arch...or Relations section of Genomic Health,s website a...
(Date:11/24/2009)... , SEATTLE, Nov. 24 ...C) management will present at the 21st Annual Pipe...ill be held December 1-2, 2009, at the New York Pa...ecember 1 at 11:00 a.m. Eastern Time in Holmes 1 (...tion will be available at www.celltherapeutics.co...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...Islands in the Clickstream is a collection of ove...n May, Thiemes book has been hailed as extremely i...ty to explore the world of technology and present ...s Andrew Briney, editor in chief of Information Se...lex interrelationship between humans and technolog...
...slands in the Clickstream is a collection of over ...May, Thiemes book has been hailed as extremely ins... to explore the world of technology and present hi...Andrew Briney, editor in chief of Information Secu...x interrelationship between humans and technology:...
...a Wisconsin-based pharmaceutical firm, reported tu... 103 percent increase in sales and raising the pre...neCare,s fourth-quarter net income has been report...ice the last quarter,s first-ever profit of $302,0...rom $7.3 million to $14.7 million, bringing the ye...
Other Biology Technology:BoneCare doubles options and profits as fiscal year closes 2
(Date:11/24/2009)...een prescribed by traditional healers in Brazil to...ach pain to fever and flu. , Now for the first ti...able to scientifically prove the pain relieving pr...razilian mint. , Testing this ancient South Ameri...ela Rocha was able to show that when prepared as a...
(Date:11/24/2009)...markable class of ring-shaped protein motors has b...keley National Laboratory (Berkeley Lab) using a s...t the Advanced Light Source (ALS). These protein m...plication, and are vital to the survival of all bi... as the human papillomavirus, which has been linke...
(Date:11/24/2009)...09) New research on bacterial communities through...ictable temporal patterns, suggesting that scienti...itoring climate change in the polar regions. The s...he National Academy of Sciences Early Edition, sh...hifted synchronously over time, correlating with s...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 1The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 4New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 1New Scientific Evidence Suggests Humans Resistant to Phthalate Effect on Lab Rodents 50095 2Research 3A Improving treatment of patients with heart attack 50093 1Research 3A Improving treatment of patients with heart attack 50093 2
...ed an effective immune response to an avian influe...e norm when they added a chemical mixture known as... issue of Clinical Infectious Diseases, now availa...that increases the immune system,s ability to resp...ators used inactivated H9N2 influenza vaccines--no...
... virus often becomes dormant, turning off its gene...rom its environment. When that trigger is pulled, ...through built-in positive-feedback loops that turn...duction of something stimulates more production of...growth.) If the viral environment were perfectly r...
...ay glued to video games this holiday season becaus...ing their basic psychological needs. , Psychologis...n with Immersyve, Inc., a virtual environment thin...keep playing. The results published in the journal...ople enjoy video games because they find them intr...
Other Biology News:A simple feedback resistor switch keeps latent HIV from awakening 2A simple feedback resistor switch keeps latent HIV from awakening 3A reason why video games are hard to give up 2
Sheep Anti-Human Factor XIII Antibody, Horseradish Peroxidase Conjugated from CEDARLANE Laboratories Limited
Immunoblot Blocking Reagent from Upstate
Rabbit Anti-DAP12 Polyclonal Antibody, Unconjugated from Exalpha Biologicals, Inc.
Amido Black 10B, CI 20470 from Research Organics, Inc.
Biology Products: